Sleep duration and snoring in relation to biomarkers of cardiovascular disease risk among women with type 2 diabetes

Diabetes Care

Volumn 30, Issue 5, 2007, Pages 1233-1240

  Williams, Catherine J ^a   Hu, Frank B ^b,c   Patel, Sanjay R ^d   Mantzoros, Christos S ^a,e  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADIPONECTIN; ANTIDIABETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT; INSULIN; THIAZIDE DIURETIC AGENT; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GLYCEMIC CONTROL; HUMAN; HUMAN EXPERIMENT; HYPERTENSION; ISCHEMIC HEART DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN ANALYSIS; QUESTIONNAIRE; SLEEP TIME; SNORING; STROKE;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD SPECIMEN COLLECTION; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; LIFE STYLE; MIDDLE AGED; PHYSICAL FITNESS; RISK FACTORS; SLEEP; SNORING; SOCIOECONOMIC FACTORS;

EID: 34247601572     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-2107     Document Type: Article

References (49)

1. National Sleep Foundation: Summary Findings of the 2005 Sleep in America Poll. Crofton, MD, WB&A Market Research, 2005, p. 6-27
2. Monk TH, Buysse DJ, Rose LR, Hall JA, Kupfer DJ: The sleep of healthy people: a diary study. Chronobiol Int 17:49-60, 2000
3. Patel SR, Ayas NT, Malhotra MR, White DP, Schernhammer ES, Speizer FE, Stampfer MJ, Hu FB: A prospective study of sleep duration and mortality risk in women. Sleep 27:440-444, 2004
4. Ayas NT, White DP, Manson JE, Stampfer MJ, Speizer FE, Malhotra A, Hu FB: A prospective study of sleep duration and coronary heart disease in women. Arch Intern Med 163:205-209, 2003
5. Gangwisch JE, Heymsfield SB, Boden-Albala B, Buijs RM, Kreier F, Pickering TG, Rundle AG, Zammit GK, Malaspina D: Short sleep duration as a risk factor for hypertension: analyses of the first National Health and Nutrition Examination Survey. Hypertension 47:833-839, 2006
6. Gottlieb DJ, Redline S, Nieto FJ, Baldwin CM, Newman AB, Resnick HE, Punjabi NM: Association of usual sleep duration with hypertension: the Sleep Heart Health Study. Sleep 29:1009-1014, 2006
7. Gangwisch JE, Malaspina D, Boden-Albala B, Heymsfield SB: Inadequate sleep as a risk factor for obesity: analyses of the NHANES I. Sleep 28:1289-1296, 2005
8. Taheri S, Lin L, Austin D, Young T, Mignot E: Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PloS Med 1:e62, 2004
9. Patel SR, Malhotra A, White DP, Gottlieb DJ, Hu FB: Association between reduced sleep and weight gain in women. Am J Epidemiol 164:947-954, 2006
10. Al Delaimy WK, Manson JE, Willett WC, Stampfer MJ, Hu FB: Snoring as a risk factor for type II diabetes mellitus: a prospective study. Am J Epidemiol 155:387-393, 2002
11. Punjabi NM, Sorkin JD, Katzel LI, Goldberg AP, Schwartz AR, Smith PL: Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 165:677-682, 2002
12. Ip MS, Lam B, Ng MM, Lam WK, Tsang KW, Lam KS: Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 165:670-676, 2002
13. Punjabi NM, Ahmed MM, Polotsky VY, Beamer BA, O'Donnell CP: Sleep-disordered breathing, glucose intolerance, and insulin resistance. Respir Physiol Neurobiol 136:167-178, 2003
14. Leineweber C, Kecklund G, Akerstedt T, Janszky I, Orth-Gomer K: Snoring and the metabolic syndrome in women. Sleep Med 4:531-536, 2003
15. Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S, D'Agostino RB, Newman AB, Lebowitz MD, Pickering TG: Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study: Sleep Heart Health Study. JAMA 283:1829-1836, 2000
16. Wolk R, Gami AS, Garcia-Touchard A, Somers VK: Sleep and cardiovascular disease. Curr Probl Cardiol 30:625-662, 2005
17. Peppard PE, Young T, Palta M, Skatrud J: Prospective study of the association between sleep-disordered breathing and hypertension. NEngl J Med 342:1378-1384, 2000
18. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V: Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 353:2034-2041, 2005
19. Marin JM, Carrizo SJ, Vicente E, Agusti AG: Long-term cardiovascular outcomes in men with obstructive sleep apnoeahypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365:1046-1053, 2005
20. Spiegel K, Leproult R, Van Cauter E: Impact of sleep debt on metabolic and endocrine function. Lancet 354:1435-1439, 1999
21. Meier-Ewert HK, Ridker PM, Rifai N, Regan MM, Price NJ, Dinges DF, Mullington JM: Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol 43:678-683, 2004
22. Shearer WT, Reuben JM, Mullington JM, Price NJ, Lee BN, Smith EO, Szuba MP, Van Dongen HP, Dinges DF: Soluble TNF-alpha receptor 1 and IL-6 plasma levels in humans subjected to the sleep deprivation model of spaceflight. J Allergy Clin Immunol 107:165-170, 2001
23. Shai I, Schulze MB, Manson JE, Stampfer MJ, Rifai N, Hu FB: A prospective study of lipoprotein(a) and risk of coronary heart disease among women with type 2 diabetes. Diabetologia 48:2691-2692, 2005
24. Vgontzas AN, Zoumakis E, Bixler EO, Lin HM, Follett H, Kales A, Chrousos GP: Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. J Clin Endocrinol Metab 89:2119-2126, 2004
25. Mantzoros CS, Li T, Manson JE, Meigs JB, Hu FB: Circulating adiponectin levels are associated with better glycemic control, more favorable lipid profile, and reduced inflammation in women with type 2 diabetes. J Clin Endocrinol Metab 90:4542-4548, 2005
26. Zhang SM, Willett WC, Selhub J, Hunter DJ, Giovannucci EL, Holmes MD, Colditz GA, Hankinson SE: Plasma folate, vitamin B6, vitamin B12, homocysteine, and risk of breast cancer. J Natl Cancer Inst 95:373-380, 2003
27. Rimm EB, Stampfer MJ, Colditz GA, Chute CG, Litin LB, Willett WC: Validity of self-reported waist and hip circumferences in men and women. Epidemiology 1:466-473, 1990
28. Hu FB, Willett WC, Li T, Stampfer MJ, Colditz GA, Manson JE: Adiposity as compared with physical activity in predicting mortality among women. N Engl J Med 351:2694-2703, 2004
29. Willett WC, Sampson L, Stampfer MJ, Rosner B, Bain C, Witschi J, Hennekens CH, Speizer FE: Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 122:51-65, 1985
30. Ayas NT, White DP, Al Delaimy WK, Manson JE, Stampfer MJ, Speizer FE, Patel S, Hu FB: A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care 26:380-384, 2003
31. Wolk R, Svatikova A, Nelson CA, Gami AS, Govender K, Winnicki M, Somers VK: Plasma levels of adiponectin, a novel adipocyte-derived hormone, in sleep apnea. Obes Res 13:186-190, 2005
32. Ebadi M, Bashir RM, Heidrick ML, Hamada FM, Refaey HE, Hamed A, Helal G, Baxi MD, Cerutis DR, Lassi NK: Neurotrophins and their receptors in nerve injury and repair. Neurochem Int 30:347-374, 1997
33. Somers VK, Dyken ME, Clary MP, Abboud FM: Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96:1897-1904, 1995
34. Shamsuzzaman AS, Gersh BJ, Somers VK: Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA 290:1906-1914, 2003
35. Ohga E, Nagase T, Tomita T, Teramoto S, Matsuse T, Katayama H, Ouchi Y: Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome. J Appl Physiol 87:10-14, 1999
36. Chin K, Nakamura T, Shimizu K, Mishima M, Nakamura T, Miyasaka M, Ohi M: Effects of nasal continuous positive airway pressure on soluble cell adhesion molecules in patients with obstructive sleep apnea syndrome. Am J Med 109:562-567, 2000
37. Yokoe T, Minoguchi K, Matsuo H, Oda N, Minoguchi H, Yoshino G, Hirano T, Adachi M: Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 107:1129-1134, 2003
38. Vgontzas AN, Papanicolaou DA, Bixler EO, Kales A, Tyson K, Chrousos GP: Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab 82:1313-1316, 1997
39. Newman AB, Nieto FJ, Guidry U, Lind BK, Redline S, Pickering TG, Quan SF: Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study. Am J Epidemiol 154:50-59, 2001
40. Grunstein RR, Stenlof K, Hedner J, Sjostrom L: Impact of obstructive sleep apnea and sleepiness on metabolic and cardiovascular risk factors in the Swedish Obese Subjects (SOS) Study. Int J Obes Relat Metab Disord 19:410-418, 1995
41. Zhang XL, Yin KS, Mao H, Wang H, Yang Y: Serum adiponectin level in patients with obstructive sleep apnea hypopnea syndrome. Chin Med J (Engl) 117:1603-1606, 2004
42. Makino S, Handa H, Suzukawa K, Fujiwara M, Nakamura M, Muraoka S, Takasago I, Tanaka Y, Hashimoto K, Sugimoto T: Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance. Clin Endocrinol (Oxf) 64:12-19, 2006
43. Harsch IA, Konturek PC, Koebnick C, Kuehnlein PP, Fuchs FS, Pour SS, Wiest GH, Hahn EG, Lohmann T, Ficker JH: Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment. Eur Respir J 22:251-257, 2003
44. Chin K, Shimizu K, Nakamura T, Narai N, Masuzaki H, Ogawa Y, Mishima M, Nakamura T, Nakao K, Ohi M: Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation 100:706-712, 1999
45. Hale CS: Obstructive sleep apnea and cardiovascular disease and mortality: the argument for causality. J Insur Med 37:272-282, 2005
46. Patel S, Malhotra A, Gottlieb DJ, White DP, Hu FB: Association between short sleep and obesity. Am J Epidemiol 164:947-954, 2006
47. Young T, Peppard PE, Taheri S: Excess weight and sleep-disordered breathing. J Appl Physiol 99:1592-1599, 2005
48. Vgontzas AN, Legro RS, Bixler EO, Grayev A, Kales A, Chrousos GP: Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance. J Clin Endocrinol Metab 86:517-520, 2001
49. Fogel RB, Malhotra A, Pillar G, Pittman SD, Dunaif A, White DP: Increased prevalence of obstructive sleep apnea syndrome in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 86:1175-1180, 2001